Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared first-in-human data from the ongoing inMMyCARTM study, a Phase 1 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback